Progress update #2: Applying the The Multiscale Pathway Mapper & Integrator to the Host's Iron-Sulfur Cluster complex(ISC) Target for Virology

Because viruses carry no autonomous metabolic machinery of their own, they cannot synthesize iron-sulfur cofactors and must hijack the human host’s iron-sulfur cluster assembly complex (ISCU) to power their core replication enzymes. However, because this same assembly line powers human mitochondrial respiration and genomic stability; a viable therapy cannot simply shut the pathway down so the framework had to map a precise route that starves the hyper-demanding viral bloom while preserving baseline host cellular survival.

The multiscale pathway mapper & integrator tracked how throttling the host iron-sulfur assembly line travels from a single protein interface up to whole-body organ survival. Each level was evaluated with a specific method.

At the molecular level; binding energetics and electrostatic surfaces were calculated across human ISCU and its heterotetrameric complex (NFS1-ISCU-ISD11-ACP) using closed-form thermodynamic models. NeRF was used to reconstruct all-atom 3D coordinates for candidate docking pockets and MolProbity checked each conformation for steric clashes. This analysis revealed a shallow, allosteric cleft distal to the catalytic zinc-coordination center, demonstrating that partial kinetic regulation was physically feasible without permanently dismantling the cluster-assembly core.

At the pathway level; curated Reactome iron-sulfur biogenesis pathways were separated into beneficial routes (host mitochondrial electron transport complexes I/II and nuclear DNA repair) and liability routes (the massive cluster drain consumed by viral RNA polymerases and helicases). An ordinary differential equation model simulated [2Fe-2S] and [4Fe-4S] intermediate flux, product transfer rates and compensatory metabolic bypasses. This dynamic simulation proved that human cells require only ~20% baseline flux to maintain survival whereas rapid viral replication demands upwards of 80% capacity.

At the tissue level; quantitative efficacy indices were computed in actively infected barrier tissues (such as respiratory epithelium) while safety margins were scored in protected, high-energy host tissues (such as cardiac myocytes, hepatocytes and renal tubules).

At the organ level; free intrabody concentrations were fed into a 14-compartment whole-body PBPK simulator. The simulator modeled intracellular tissue penetration, hepatic clearance and lymphatic distribution to ensure that target occupancy remained tightly controlled across vital organs.

The stiff differential equations governing pathway flux and whole-body distribution were integrated using SciPy’s LSODA and Radau solvers establishing the precise quantitative boundary where viral replication halts while host tissues remain unharmed.

What changed: We were able to trace how modulating the molecular ISC target travels through metabolic pathways to whole-body circulation, establishing the quantitative boundary where viral replication is starved while baseline host cellular survival is preserved.

What's next: We'll cover the next component of the framework: context-aware adapters.